LAWRENCE, Mass., Jan. 16, 2017 /PRNewswire/ -- NxStage Medical,
Inc. (Nasdaq: NXTM), a leading medical technology company focused
on advancing renal care, today announced plans to release its
financial results for the fourth quarter and full year ended
December 31, 2016, on Tuesday, February 28, 2017, before the opening of
the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Tuesday, February 28, 2017, to discuss its fourth
quarter and full year financial results. To listen to the
conference call, please dial 877-392-9886 (domestic) or
707-287-9329 (international). The call will also be webcast LIVE
and can be accessed via the investor relations section of the
Company's website at http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through March 8, 2017. To access the replay, dial
855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 51587452. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq:
NXTM) is a leading medical technology company, headquartered in
Lawrence, Massachusetts, USA, that
develops, manufactures and markets innovative products for the
treatment of end-stage renal disease (ESRD) and acute kidney
failure. NxStage also has established a small number of dialysis
clinics committed to the development of innovative care delivery
models for patients with ESRD. For more information on NxStage and
its products and services, please visit the Company's websites at
www.nxstage.com and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. The forward-looking
statements in this Release include NxStage's plan to release its
financial results on February 28,
2017. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including those that are discussed in
NxStage's filings with the Securities and Exchange Commission,
including the Quarterly Report on Form 10-Q for the quarter ended
September 30, 2016. NxStage is under
no obligation to (and expressly disclaims any such obligation to)
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-fourth-quarter-and-full-year-2016-financial-results-300391300.html
SOURCE NxStage Medical, Inc.